Spain · Delayed Price · Currency is EUR Biotechnology Assets Statistics
Total Valuation
BME:BST has a market cap or net worth of EUR 18.57 million. The enterprise value is 19.48 million.
| Market Cap | 18.57M |
| Enterprise Value | 19.48M |
Important Dates
The last earnings date was Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:BST has 74.29 million shares outstanding.
| Current Share Class | 74.29M |
| Shares Outstanding | 74.29M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.09% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.41 |
| PB Ratio | 2.67 |
| P/TBV Ratio | 6.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.60, with an EV/FCF ratio of -1,290.92.
| EV / Earnings | -10.17 |
| EV / Sales | 5.68 |
| EV / EBITDA | 15.60 |
| EV / EBIT | n/a |
| EV / FCF | -1,290.92 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.40 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.27 |
| Debt / FCF | -104.70 |
| Interest Coverage | -5.69 |
Financial Efficiency
Return on equity (ROE) is -28.25% and return on invested capital (ROIC) is -21.80%.
| Return on Equity (ROE) | -28.25% |
| Return on Assets (ROA) | -3.38% |
| Return on Invested Capital (ROIC) | -21.80% |
| Return on Capital Employed (ROCE) | -7.45% |
| Weighted Average Cost of Capital (WACC) | 13.78% |
| Revenue Per Employee | 114,388 |
| Profits Per Employee | -63,869 |
| Employee Count | 30 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:BST has paid 319,968 in taxes.
| Income Tax | 319,968 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.30% in the last 52 weeks. The beta is 1.84, so BME:BST's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -18.30% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 48.94 |
| Average Volume (20 Days) | 129,987 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:BST had revenue of EUR 3.43 million and -1.92 million in losses.
| Revenue | 3.43M |
| Gross Profit | 3.20M |
| Operating Income | -766,981 |
| Pretax Income | -1.60M |
| Net Income | -1.92M |
| EBITDA | 1.25M |
| EBIT | -766,981 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 666,218 in cash and 1.58 million in debt, with a net cash position of -913,942 or -0.01 per share.
| Cash & Cash Equivalents | 666,218 |
| Total Debt | 1.58M |
| Net Cash | -913,942 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 6.96M |
| Book Value Per Share | n/a |
| Working Capital | 1.32M |
Cash Flow
In the last 12 months, operating cash flow was -13,108 and capital expenditures -1,984, giving a free cash flow of -15,092.
| Operating Cash Flow | -13,108 |
| Capital Expenditures | -1,984 |
| Depreciation & Amortization | 338,090 |
| Net Borrowing | -1.22M |
| Free Cash Flow | -15,092 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 93.27%, with operating and profit margins of -22.35% and -55.84%.
| Gross Margin | 93.27% |
| Operating Margin | -22.35% |
| Pretax Margin | -46.53% |
| Profit Margin | -55.84% |
| EBITDA Margin | 36.40% |
| EBIT Margin | -22.35% |
| FCF Margin | n/a |
Dividends & Yields
BME:BST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -10.32% |
| FCF Yield | -0.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |